PAMU
AGN

Pictet Asset Management (UK)’s Allergan plc AGN Stock Holding History

Pictet Asset Management (UK)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-157,786
Closed -$27.9M – 1230
2020
Q1 		$27.9M Buy
157,786
+7,800
+5% +$1.47M 0.06% 305
2019
Q4 		$35.2M Buy
+149,986
New +$27.1M 0.06% 342
2013
Q4 		– Sell
-94,848
Closed -$13.7M – 888
2013
Q3 		$13.7M Buy
94,848
+14,103
+17% +$1.88M 0.08% 271
2013
Q2 		$10.2M Buy
+80,745
New +$9.14M 0.06% 319

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Pictet Asset Management (UK)'s AGN Position: Q2 2020 in Review

Pictet Asset Management (UK) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 157,786 shares — an estimated $27.9M sold.

Pictet Asset Management (UK) first reported a position in AGN in Q2 2013 and held it in 4 quarters. The position peaked at $35.2M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Pictet Asset Management (UK) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 157,786 Allergan plc shares in Q2 2020, an estimated $27.9M.
  • Pictet Asset Management (UK) first reported a position in Allergan plc in Q2 2013 and held it in 4 quarters.
  • Pictet Asset Management (UK)'s Allergan plc position peaked at $35.2M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2020, filed 13 Aug 2020.